Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.855 USD | -3.13% | -8.45% | -26.14% |
04-08 | Transcript : Cue Biopharma, Inc., Q4 2023 Earnings Call, Apr 08, 2024 | |
04-08 | North American Morning Briefing : Inflation Data, -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.14% | 93.15M | |
+2.75% | 108B | |
+10.25% | 104B | |
+2.42% | 22.33B | |
-11.82% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.15% | 17.64B | |
+6.41% | 14.05B | |
+35.50% | 12.51B |
- Stock Market
- Equities
- CUE Stock
- News Cue Biopharma, Inc.
- Piper Sandler Adjusts Price Target on Cue Biopharma to $8 From $7, Maintains Overweight Rating